Daniel Paris
11Patents
2h-index
8Co-inventors
47Inventor score
Filing activity: Jul 13, 1999 → Mar 4, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10984034B1 | Dialogue management system with hierarchical classification and progression | Physics | 12 | Active |
| US7589168B2 | Inhibition of angiogenesis by A-β peptides | Physics | 4 | Expired |
| US8481637B2 | Co-extrudable thermoplastic elastomer compound for blow molded plastic articles | Emerging Cross-Sectional Technologies | 2 | Active |
| US8067372B2 | Modulation of angiogenesis by A-beta peptide fragments | Human Necessities | 2 | Active |
| US11865107B2 | Pharmaceutical composition | Human Necessities | 0 | Active |
| US7605149B1 | Modulation of the phospholipase A2 pathway as a therapeutic | Human Necessities | 0 | Expired |
| US9149751B2 | Liquid knockout drum | Mechanical Engineering; Lighting; Heating | 0 | Active |
| US8236346B2 | Method for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis with (-)-nilvadipine enantiomer | Human Necessities | 0 | Active |
| US7732467B2 | Method for reducing amyloid deposition, amyloid neurotoxicity and microgliosis | Human Necessities | 0 | Active |
| US11625425B2 | Dialogue management system with hierarchical classification and progression | Physics | 0 | Active |
| US8236347B2 | Pharmaceutical compositions for reducing amyloid deposition, amyloid neurotoxicity, and microgliosis | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.